Guoming Li

Osteoclast precursor cell membrane-engineered bone-targeting calcium carbonate nanoparticles for anti-osteoporosis therapy

Osteoporosis (OP) is a metabolic bone disease characterized by reduced bone mass and deterioration of bone microarchitecture, resulting in an increased risk of fragility fractures. Current anti-osteoporotic therapies are often limited by poor targeting efficiency, suboptimal ther...